1160097

Alexion Pharmaceuticals, Inc. — FEI 3014801948

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
December 17, 2021
Fiscal Year
2022
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Boston, MA (United States)

Additional Details

Risk Evaluation and Mitigation Strategies (REMS)